MANAGEMENT OF BCC IN A TERTIARY CARE CENTER OF MALWA REGION OF PUNJAB: A CASE SERIES
Main Article Content
Keywords
Abstract
Basal cell carcinoma, the most common type of skin cancer, arises from the basal cells of the skin's outer layer. The primary etiological factor in the development of basal cell carcinoma is exposure to UV light, particularly the UVB wavelengths. The great majority of patients with BCC (95%) are noted to be between 40 and 79 years of age. BCC most commonly occurred over orbital (28.2%) and nasal (26.7%) areas on the face. Treatment of BCC include wide local excision followed by reconstruction. 60 patients with primary BCC, who presented to OPD department of Plastic Surgery and referred from Oncology department of GGSMCH, Faridkot were included in the study with minimum follow up for 6 months. Approximately seventy percent of Punjab's population is directly or indirectly engaged in agriculture. In our study, the majority of cases (82%) belonged to an agricultural background with a history of prolonged sun exposure while working in the fields. The most common incidence was seen in the sixth and fifth decade of life (33.3% and 30.00% respectively). The most common site involved was nose (35.00%) followed by cheeks (21.67%) and eyelids and canthi (16.67%). 53.33% of defects were reconstructed using flaps, 25% using skin grafting and elliptical excision followed by primary closure was done for 21.67% of the patients. While split-thickness skin grafting is a simpler choice, it tends to result in unsightly scars as it heals. Local flaps, on the other hand, provide a superior match in terms of color and texture and also maintain sensitivity, making them an ideal choice for reconstructing facial defects.
References
2. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ. Basal cell carcinoma: what’s new under the sun. Photochemistry and photobiology. 2010 May;86(3):481-91.
3. Lomas AL, Leonardi‐Bee J, Bath‐Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. British Journal of Dermatology. 2012 May 1;166(5):1069-80.
4. Zhang W, Zeng W, Jiang A, He Z, Shen X, Dong X, Feng J, Lu H. Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Cancer medicine. 2021 Jul;10(14):4905-22.
5. Labani S, Asthana S, Rathore K, Sardana K. Incidence of melanoma and nonmelanoma skin cancers in Indian and the global regions. Journal of cancer research and therapeutics. 2021 Jul 1;17(4):906-11.
6. Muzic JG, Schmitt AR, Wright AC, Alniemi DT, Zubair AS, Lourido JM, Seda IM, Weaver AL, Baum CL. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. InMayo Clinic Proceedings 2017 Jun 1 (Vol. 92, No. 6, pp. 890-898). Elsevier.
7. Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019 Feb;80(2):303-317.
8. Fijałkowska M, Koziej M, Antoszewski B. Detailed head localization and incidence of skin cancers. Scientific Reports. 2021 Jun 11;11(1):12391.
9. McDaniel B, Badri T, Steele RB. Basal Cell Carcinoma. [Updated 2022 Sep 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.
10. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Modern pathology. 2006 Jan 1;19:S127-47.
11. E. Bichakjian C, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, Eisen DB, Iyengar V, Lober C, Margolis DJ, Messina J. Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology. 2018 Mar 1;78(3):540-59.
12. McDaniel B, Badri T, Steele RB. Basal cell carcinoma.[Updated 2020 Nov 20]. StatPearls [Internet]. Treasure Island (FL): Stat-Pearls Publishing. 2021.
13. Verkouteren JA, Ramdas KH, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. British Journal of Dermatology. 2017 Aug 1;177(2):359-72.
14. Ciążyńska M, Kamińska-Winciorek G, Lange D, Lewandowski B, Reich A, Sławińska M, Pabianek M, Szczepaniak K, Hankiewicz A, Ułańska M, Morawiec J. The incidence and clinical analysis of non-melanoma skin cancer. Scientific reports. 2021 Feb 22;11(1):4337
15. Raina RK, Mahajan VK, Bodh TD, Chander B, Chandel SS, Mehta KS. Basal cell carcinoma: A 6-year clinicopathological study from the Sub-Himalayan region of North India. CHRISMED Journal of Health and Research. 2019 Oct 1;6(4):254-8.
16. Kumar S, Mahajan BB, Kaur S, Yadav A, Singh N, Singh A. A study of basal cell carcinoma in South Asians for risk factor and clinicopathological characterization: A hospital based study. Journal of skin cancer. 2014 Jan 1;2014.
17. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–2269.
18. Wollina U. Epithelial tumors of the outer nose. Indian Journal of Dermatology. 2003 Oct 1;48(04):194.
19. Levy RM, Hanke CW. Mohs micrographic surgery: facts and controversies. Clinics in dermatology. 2010 May 1;28(3):269-74.